WCLC 2025 - Posters & ePosters-P2.02.34 Synergistic Antitumor Effect of an XPO1 Inhibitor And/Or Sotorasib With V-ATPase Inhibitors Pretreatment in KRAS G12C NSCLC

P2.02.34 Synergistic Antitumor Effect of an XPO1 Inhibitor And/Or Sotorasib With V-ATPase Inhibitors Pretreatment in KRAS G12C NSCLC

Asset Subtitle

Jessica González

Meta Tag

Speaker Jessica González

Topic Tumor Biology – Preclinical Biology